BIOMIND LABS INC. Financial Flexibility Index
BIOMIND LABS INC. financial flexibility index. BIOMIND LABS INC. (3XI) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of €-38.70K (operating CF €-38.70K minus capex €0.00) represents 0% of total liabilities (€1.62 Million). See 3XI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BIOMIND LABS INC. (2021–2024)
Financial flexibility index of BIOMIND LABS INC. from 2021 to 2024. Historical Financial Flexibility Index trend for BIOMIND LABS INC. across 4 annual periods. Check 3XI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
BIOMIND LABS INC. Financial Flexibility Index by Year (2021–2024)
BIOMIND LABS INC. financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for BIOMIND LABS INC.. For the full cash flow conversion analysis, see BIOMIND LABS INC. operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €-2.15 Million | €336.72K | ▼ -3.0% |
| 2021 | -6.20x | €-2.08 Million | €-2.12 Million | €334.95K | — |